Comparison Tool

Select a country from the regions above then, add your country to our comparison tool to compare country specific information simultaneously across 3 countries


Fast Facts

  • Capital: Bogotá
  • Economy: free market economy. Nominal GDP US$283.109 billion
  • Health Expenditure: 5.9% of GDP, 2008
  • Population: 49 million, 2017
  • Average Life Span: 75.2 years, 2010
  • Languages: Spanish
  • Adult Literacy Rate: 93%

Health Trends

  • Major Infectious Diseases: HIV/ AIDS,  Hepatitis A, Hepatitis C, Typhoid Fever, Malaria, Dengue Fever, Yellow Fever, Meningococcal Meningitis
  • Healthcare system divided into two groups: Private & public


Clinical Trial Landscape

  • 4th largest Latin American pharmaceutical market
  • 325 clinical trials to date (Phase I, II and IIIb)
  • Opportunities in metabolics, hypertension and oncology
  • Majority of the market is supplied by the relatively well-developed domestic industry
    • To date, five national regulatory authorities have been recognised by PAHO/WHO as National Regulatory Authorities of Regional Reference, one of them being the National Institute of Food and Drug Monitory of Colombia (INVIMA).
    • Clinical Investigation Sites are certified by INVIMA in GCP compliance

ICON in Colombia

Add to Comparison Tool
  • Established in 2008
  • 44 Employees, 2017
  • Total awarded studies: 43 (2008 - YTD 2012), and currently participating in 20 studies in various therapeutic areas including Oncology, Diabetes, Cardiovascular, HIV, Gastric Disorders, Psoriasis and Transplants
  • Majority of studies in Oncology, Cardiovascular, Metabolics and Dermatology 

Services Offered

  • Clinical Monitoring
  • Study start-up and Feasibility
  • Medical & Safety Services
  • Late Phase Research (Ph IV)
  • Coverage of other Central American countries (recent examples including Panama, Costa Rica & Dominican Republic)
  • Logistics
  • DOCS Resourcing Solutions 
    • Functional Resourcing  
    • Flexible Resourcing 
    • Permanent Recruitment 

Contact Us for further information